Decibel Therapeutics

@DecibelTx

Decibel is translating cutting-edge science into hearing therapeutics to create a world in which the benefits and joys of hearing are available to all.

Vrijeme pridruživanja: siječanj 2017.

Tweetovi

Blokirali ste korisnika/cu @DecibelTx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @DecibelTx

  1. 29. sij

    We're excited to announce a new strategic research focus on regenerative medicine approaches for the inner ear, including a collaboration and option agreement with The Rockefeller University to license a novel series of small-molecule LATS inhibitors:

    Poništi
  2. 29. sij

    Today we announced the appointment of Laurence Reid, Ph.D., as our acting chief executive officer. CEO Steven Holtzman is retiring and will become a strategic business advisor to the company. More here:

    Poništi
  3. 24. sij

    In the coming days, our team will make several presentations at , including a symposium from Dr. Jonathon Whitton, our director of clinical development, on developing for hearing loss. See the full schedule here:

    Poništi
  4. 24. sij

    We're looking forward to presenting new findings from several of our drug discovery and development programs at the annual meeting of the Association for Research in Otolaryngology (). For details, see our press release:

    Poništi
  5. 20. pro 2019.

    Best wishes for a safe and happy holiday season from !

    Poništi
  6. 22. stu 2019.

    Our CMO Peter Weber recently spoke to of about Decibel's work to develop a therapy targeting cisplatin-induced hearing loss. Read the article here:

    Poništi
  7. 14. stu 2019.

    Listen to our chief data sciences officer, John Keilty, discuss his work at Decibel and and the critical role of data in on :

    Poništi
  8. 7. stu 2019.

    We recommend listening to this interview with David Owen of the on . Owen discusses his new book, “Volume Control,” and hits on many of the diverse challenges that permeate research. Check it out:

    Poništi
  9. 28. lis 2019.

    Thanks to the for hosting a great event at yesterday's 2019 New England . Rain or shine, is always glad to participate and to show our support for the community!

    Poništi
  10. 17. lis 2019.

    . does great things for those with . We had a blast supporting their annual during our 3rd annual Decibel poker tournament. Thanks to all on who made it happen and congrats to our 1st place winner, CMO Rob Ross!

    Poništi
  11. 7. lis 2019.

    Decibel is presenting a corporate update tomorrow at the Gene Therapy Summit in New York City. President and CEO Steven Holtzman will present at 9:45 a.m. ET. More here:

    Poništi
  12. 3. lis 2019.

    to last year's ! Each year, the hosts the Walk 4 Hearing across the country to bring the community together. Team Decibel is ready for the 2019 walk -- learn about how you can join the event here:

    Poništi
  13. 26. ruj 2019.

    Our bioinformatics work, led by talented researchers like Gabi, provides the foundation for our discovery of novel targets involved in inner ear dysfunction. It's a critical step in our mission to develop therapeutics.

    Poništi
  14. 20. ruj 2019.

    This recent article explores the link between age-related and loneliness through the eyes of 68-year-old Anne Madison. With age-related hearing loss, "You're cut off. It's a horrible way to be," Anne says. More here:

    Poništi
  15. 21. kol 2019.

    This video, captured by Decibel scientists, shows the positioning of vestibular neurons and axons in the inner ear. Variations in color correspond to depth within three-dimensional space.

    Poništi
  16. 19. kol 2019.

    Last week enjoyed some fun in the sun at our annual summer picnic!

    Poništi
  17. 15. kol 2019.

    There's a fast-growing body of research linking with reduced quality of life. Most recently, researchers reviewed a survey of living conditions in Japan and found correlations with psychological distress and memory loss, among other factors:

    Poništi
  18. 12. kol 2019.

    Congrats to Mark Levin, of , for receiving 's Lifetime Achievement Award! In the words of our CEO, Steve Holtzman, "Mark creates great conditions for great people to do great things." More here:

    Poništi
  19. 9. kol 2019.

    Jonathon Whitton, our director of clinical development, was recently named to 's list of 30 researchers under 40 for his work to transform the future of therapeutics. Way to go, Jonathon! More here (paywall):

    Poništi
  20. 26. srp 2019.

    : We recently appointed Christine Poon to our BoD. She joins a team of diverse biotech leaders combining forces to develop breakthrough therapeutics for hearing and balance. Visit our website to learn more about our team and collaborators:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·